GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » Gross Margin %

Cordlife Group (SGX:P8A) Gross Margin % : 66.21% (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Cordlife Group's Gross Profit for the six months ended in Dec. 2023 was S$18.15 Mil. Cordlife Group's Revenue for the six months ended in Dec. 2023 was S$27.42 Mil. Therefore, Cordlife Group's Gross Margin % for the quarter that ended in Dec. 2023 was 66.21%.


The historical rank and industry rank for Cordlife Group's Gross Margin % or its related term are showing as below:

SGX:P8A' s Gross Margin % Range Over the Past 10 Years
Min: 64.45   Med: 67.71   Max: 72.99
Current: 66.94


During the past 12 years, the highest Gross Margin % of Cordlife Group was 72.99%. The lowest was 64.45%. And the median was 67.71%.

SGX:P8A's Gross Margin % is ranked better than
76.08% of 209 companies
in the Medical Diagnostics & Research industry
Industry Median: 46.64 vs SGX:P8A: 66.94

Cordlife Group had a gross margin of 66.21% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Cordlife Group was 0.90% per year.


Cordlife Group Gross Margin % Historical Data

The historical data trend for Cordlife Group's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group Gross Margin % Chart

Cordlife Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.45 67.99 69.67 67.43 66.94

Cordlife Group Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.47 66.99 67.82 67.64 66.21

Competitive Comparison of Cordlife Group's Gross Margin %

For the Diagnostics & Research subindustry, Cordlife Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordlife Group's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cordlife Group's Gross Margin % falls into.



Cordlife Group Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Cordlife Group's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=37.3 / 55.73
=(Revenue - Cost of Goods Sold) / Revenue
=(55.73 - 18.425) / 55.73
=66.94 %

Cordlife Group's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=18.2 / 27.417
=(Revenue - Cost of Goods Sold) / Revenue
=(27.417 - 9.264) / 27.417
=66.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cordlife Group  (SGX:P8A) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cordlife Group had a gross margin of 66.21% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Cordlife Group Gross Margin % Related Terms

Thank you for viewing the detailed overview of Cordlife Group's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cordlife Group (SGX:P8A) Business Description

Traded in Other Exchanges
Address
1 Yishun Industrial Street 1, Number 06-01/09, A'Posh Bizhub, Singapore, SGP, 768160
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group (SGX:P8A) Headlines

No Headlines